Oncolytics Biotech Inc. believes in a transparent and forward-facing approach to business.
Committee Charters
Board of Directors Mandate
Audit Committee Mandate
Compensation Committee Mandate
Corporate Governance Committee Mandate
Science and Technology Committee Mandate
Governance Documents
Code of Ethics for CEO, CFO and Accounting Officers
Employee Code of Ethics
Corporate Trading Policy
Policy on Trading and Confidential Information
Policy Regarding Accounting and Auditing Matters
Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More
Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More
Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More
